home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Oncogenic microRNA

  March, 20 2008 8:41
your information resource in human molecular genetics

Scientists have discovered how a particular cluster of short strings of genetic material called microRNAs promotes lymphoma development, according to a paper published online in Nature Immunology. These findings will aid our understanding of the biological processes at work during the early stages of this cancer.

Klaus Rajewsky and colleagues set out to determine how the miR-17-92 microRNA cluster -- frequently amplified in lymphoma cells -- accelerates lymphoma development. The team studied mice with elevated amounts of miR-17-92 matching those seen in lymphoma cells. These mice displayed hyperproliferation of lymphocytes, suffered from autoimmune disease and then died prematurely.

The researchers identified miR-17-92-binding sites in RNA molecules encoding Bim and PTEN, proteins known to protect cells from cancer development. Supporting the notion that miR-17-92 promotes lymphoma development by diminishing expression of tumour suppressor proteins, mice expressing reduced Bim and PTEN displayed some features of mice overexpressing miR-17-92. These findings will direct future efforts to identify additional factors contributing to early lymphomagenesis.

Author contact:

Klaus Rajewsky (Harvard Medical School, Boston, MA, USA)
E-mail: rajewsky@cbr.med.harvard.edu

Abstract available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.